Affiliation:
1. Department of Spine, Hengshui People’s Hospital, Hebei, 053000, China
Abstract
This article detects the drug-carrying capacity of the new chitosan/silk fibroin/nano-hydroxyapatite multilayer composite scaffold and analyzes its efficacy in postoperative care of orthopedic fractures. The article uses animal experiments for comparative analysis. All animals undergo
fracture model establishment. One group uses nano three-dimensional scaffold materials loaded with antibiotics, one group is pure nano three-dimensional scaffold materials, and the last group is without any implantation treatment. Finally, it was found that the fracture recovery of the three
groups of animals was different. In particular, all the antibiotic-loaded nano three-dimensional scaffold material group indicators are better than the other two groups. For this reason, we conclude that the new chitosan/silk fibroin/nano-hydroxyapatite multilayer composite scaffold has a
strong drug-carrying capacity. The stent is worthy of clinical promotion and use in orthopedics.
Publisher
American Scientific Publishers
Subject
Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology